Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ludo Reynders joins Premier Research Group

This article was originally published in Clinica

Executive Summary

Contract research organisation Premier Research Group has appointed Ludo Reynders CEO. Dr Reynders was previously CEO of AAIPharma, which he transformed from a pharma company specialising in pain into a drug development services firm. Before this, he worked for Quintiles Translational Corporation for 16 years in several positions including managing director of pharmabio development and CEO of Quintiles Development Services. He was also employed by Bristol Myers for seven years. Philadelphia, Pennsylvania-based Premier Research carries out trials in the analgesia, oncology, neuroscience and cardiovascular fields, and also has experience in medical device and paediatric research.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095974

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel